Aktis Oncology, Inc.
Aktis Oncology is dedicated to transforming cancer care through the development of novel platform technologies that enable the design and development of powerful precision radiopharmaceuticals. These targeted therapies harness the superior anticancer potency of alpha-emitting particles to impact tumors with currently limited treatment options, aiming to improve outcomes and achieve higher cure rates for solid cancers.
Industries
Nr. of Employees
small (1-50)
Aktis Oncology, Inc.
Patents
Products
Radiopharmaceuticals
Aktis Oncology develops alpha-emitting radiopharmaceuticals that target and destroy cancer cells while minimizing harm to healthy cells.
Nectin-4 Targeting Program
A clinical-stage program focused on targeting Nectin-4, a protein found in various cancers, to deliver alpha radiotherapy.
Pipeline of Targeting Molecules
Aktis Oncology is developing a pipeline of seven proprietary programs aimed at delivering alpha radiotherapy to a range of cancers including breast, lung, colorectal, bladder, and liver cancers.
Theranostic Approach
Aktis Oncology uses imaging tools to visualize and verify tumor target engagement, allowing better prediction of patient response to radiopharmaceutical therapy.
Manufacturing and Delivery
Aktis Oncology ensures just-in-time delivery of radiopharmaceuticals by managing the entire manufacturing process to maintain drug efficacy.
Radiopharmaceuticals
Aktis Oncology develops alpha-emitting radiopharmaceuticals that target and destroy cancer cells while minimizing harm to healthy cells.
Nectin-4 Targeting Program
A clinical-stage program focused on targeting Nectin-4, a protein found in various cancers, to deliver alpha radiotherapy.
Pipeline of Targeting Molecules
Aktis Oncology is developing a pipeline of seven proprietary programs aimed at delivering alpha radiotherapy to a range of cancers including breast, lung, colorectal, bladder, and liver cancers.
Theranostic Approach
Aktis Oncology uses imaging tools to visualize and verify tumor target engagement, allowing better prediction of patient response to radiopharmaceutical therapy.
Manufacturing and Delivery
Aktis Oncology ensures just-in-time delivery of radiopharmaceuticals by managing the entire manufacturing process to maintain drug efficacy.